Company profile
Chordate Medical company profile
Chordate is a medical technology company that for ten years has developed and patented OZILIA® a new treatment method for chronic migraine and chronic nasal congestion. The global pharmaceutical market for migraine treatments is estimated to amount to approximately SEK 83.7 billion per year within six years. The company offers a CE-marked and patented OZILIA® treatment for chronic migraine and rhinitis. Chordate's treatment has been introduced in selected European and markets in the Middle East.
Business identity
- Website
- https://www.chordate.com/
- Phone number
- +46 8 400 115 86
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2005-01-01, Year
Headquarters
- Headquarters
- Kista, Stockholm, Sweden
- Postal code
- 164 40
- Country code
- SE
- Continent
- Europe